This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Clorox (CLX) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Clorox (CLX) closed at $142.59 in the latest trading session, marking a +0.37% move from the prior day.
Clorox (CLX) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Clorox (CLX) reachead $141.86 at the closing of the latest trading day, reflecting a +0.5% change compared to its last close.
Clorox (CLX) Ascends But Remains Behind Market: Some Facts to Note
by Zacks Equity Research
Clorox (CLX) closed at $141.16 in the latest trading session, marking a +0.4% move from the prior day.
Clorox's (CLX) Growth Strategies Seem Encouraging: Here's Why
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy bodes well. The company's pricing and cost-saving initiatives are aiding margins and, in turn, profitability.
Why Clorox (CLX) Dipped More Than Broader Market Today
by Zacks Equity Research
In the closing of the recent trading day, Clorox (CLX) stood at $141.91, denoting a -0.19% change from the preceding trading day.
Clorox (CLX) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $141.55, marking a -1.46% move from the previous day.
RBGLY or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
RBGLY vs. CLX: Which Stock Is the Better Value Option?
Clorox (CLX) Up 16.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pinterest and Clorox have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Pinterest and Clorox have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Clorox (CLX)
by Andrew Rocco
Clorox is facing significant challenges after a sophisticated cyber-attack disrupted its operations. Despite its reputation as a value stock, CLX's overvaluation, negative quarterly EPS growth, and declining stock prices are concerning.
Pricing Aids Clorox's (CLX) Q1 Earnings Amid Cyberattack Woes
by Zacks Equity Research
Clorox's (CLX) Q1 results reflect the impacts of lower volume due to the recent cyberattack. However, results are largely offset by its pricing actions and cost-saving initiatives.
Compared to Estimates, Clorox (CLX) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Clorox (CLX) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Clorox (CLX) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
The latest trading day saw Clorox (CLX) settling at $116.55, representing a -1.17% change from its previous close.
Looming Cyber Attack Effects to Hurt Clorox's (CLX) Q1 Earnings
by Zacks Equity Research
Clorox's (CLX) Q1 performance is anticipated to have witnessed headwinds from the looming effects of the recent cyber security attack, which has disrupted operations and caused product shortages.
Colgate-Palmolive (CL) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 7.50% and 2.06%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Clorox (CLX) closed at $121.99 in the latest trading session, marking a -0.66% move from the prior day.
Lamb Weston and Clorox have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Lamb Weston and Clorox have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: The Clorox Company (CLX)
by Benjamin Rains
Clorox's near-term outlook appears disappointing, driven lower by a recent cybersecurity attack that was disclosed in August.
Clorox (CLX) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $124.04, moving -0.74% from the previous trading session.
Procter and Gamble Earnings: Can Strong Retail Sales Trigger a Beat?
by Ethan Feller
Just this morning we found out that US retail sales jumped 0.7% in September. Can this positive wave carry Procter and Gamble¿¿¿s earnings as well?
Can Clorox (CLX) Rebound on Pricing & Cost-Saving Efforts?
by Zacks Equity Research
Solid demand, pricing actions, cost-saving efforts and other growth strategies are likely to aid Clorox's (CLX) performance in the near future.
Clorox (CLX) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Clorox (CLX) concluded the recent trading session at $123.11, signifying a -1.51% move from its prior day's close.
Company News for Oct 6, 2023
by Zacks Equity Research
Companies in The News Are: CAG, CLX, LW, PEP
Clorox (CLX) Unveils Preliminary Q1 Results, Hurt by Cyber Attack
by Zacks Equity Research
Clorox's (CLX) Q1 preliminary update reveals significant challenges due to a cybersecurity attack that disrupted its operations.